UFP Technologies posted Q2 net income up 21.4% to USD 20.9 million; GAAP diluted EPS rose to USD 2.68.
Net sales climbed 15.1% to USD 174 million; gross margin widened 0.5 percentage points to 29.3%.
Operating income increased 15.5% to USD 28.1 million; SG&A rose 21.8% to USD 22.8 million.
Six-month performance and management commentary
Six-month net income rose 11.6% to USD 38.3 million; net sales increased 9.6% to USD 328.2 million.
Management cited broad-based MedTech growth, ongoing investment in Dominican Republic operations, and near-term mix and margin pressure in U.S. operations.
UFPT•
